News

Agrospheres Seeks EPA Approval For Inert Ingredient

AgroSpheres, Inc. progresses toward a key milestone in reducing pesticide impact in the environment. The submission of AgroSpheres™ Inert ingredient to the US Environmental Protection Agency (EPA) for use in agriculture inputs will further the company’s objective to make biopesticides more effective and reduce the rates of synthetic pesticide application. When approved, this technology will power a suite of environmentally-friendly crop health products for organic and conventional farming.

“The EPA submission marks our first major milestone towards the commercial establishment of our biorational portfolio which will bring sustainable products to our farmers and sustainable returns to our shareholders,” said Payam Pourtaheri, AgroSpheres’ CoFounder and CEO.

AgroSpheres™ Inert is a non-GM, fermentation-derived technology that will enhance biorational products. By replacing conventional inert ingredients like solvents and microplastics, this new technology will create an effective, biobased and biodegradable product line for growers.

“With this initial EPA submission, we are on track to deliver the first organic, inert technology that can transform the performance of both biological and synthetic pesticides,” said AgroSpheres’ CoFounder and CTO Ameer Shakeel. “Growers and investors can be confident we’re producing this ingredient in a controlled, zero-waste and proprietary bioprocess.”

“The AgroSpheres inert technology is both simple and elegant”, said Jerry Hjelle, Ph.D., AgroSpheres Scientific Advisor. “It is produced from a well-understood microbe with an established safety history. It enables a sustained release of organic, biological and conventional pesticides, creating the opportunity to reduce global pesticide use. The non-viable inert ingredient degrades in soil just like any other soil microorganism. This innovative approach to protecting organic and conventional foods and feeds has great potential.”

AgroSpheres developed the Inert technology to power eco-friendly ag product performance and significantly reduce chemical usage. The company is engaging leading global commercial partners that will enable broad access to reliable and novel biorational products. AgroSpheres™ Inert technology will empower crop health products that move us closer to realizing the company’s vision of a future built by nature’s technologies.

Recent News

09/17/2026

Rivanna Announces New CMS Procedure Code for Computer-aided Neuraxial Guidance

RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the Centers for Medicare & Medicaid Services (CMS) has established ICD-10-PCS code XEZU3HC, effective for inpatient discharges beginning October 1, 2026. The code identifies computer-aided intraprocedural navigation in the spinal canal using ultrasound imaging with continuous needle tracking via a percutaneous approach during neuraxial anesthesia.

09/17/2026

From Lab to Three Continents: Agrospheres and FMC Corporation Advance Bioinsecticide Pipeline into Global Field Trials

AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection and FMC Corporation (NYSE: FMC), a global leader in agricultural sciences, today announced a significant advancement in its ongoing collaboration. Two proprietary RNA-based biomolecule candidates from AgroSpheres’ pipeline are now entering global field trial development, marking the transition from discovery into real-world testing across three

09/15/2026

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (“Jazz” or the “Company”) today announced the successful completion of its acquisition of privately-held Actio Biosciences, Inc. (“Actio”) for $820 million upfront. Actio is now a wholly-owned subsidiary of Jazz. “ABS-1230 holds the promise of being a transformative, first-in-class therapy for individuals living with KCNT1-related epilepsy,” said Renee Gala, president and